Biocotron
NDC Package 45737-209-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Biocotron is other information store at controlled room temperature20-25 C (68-77 F); excursion permitted to 15-30 C (59-86 F). Marketed by Advanced Generic Corporation, this product is identified by NDC 45737-209 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
45737-209-16
Package Description
473 mL in 1 BOTTLE
Product Code
45737-209
11-Digit Billing Format
45737020916
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML
RxNorm Crosswalk
  • RxCUI: 996520 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Biocotron
Dosage Form
-
Usage Information
Other information store at controlled room temperature20-25 C (68-77 F); excursion permitted to 15-30 C (59-86 F). Tamperevident by imprinted heat seal under cap. Do not use if there isevidence of tampering.Warning: Phenylketonuric: Contains 11.25 mg of phenylalanine per 5 ml (one teaspoonful) dose.

Regulatory & Marketing

Labeler Name
Advanced Generic Corporation
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2009
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45737-209-16 identifies a specific commercial package of 473 ml in 1 bottle of Biocotron, labeled by Advanced Generic Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Advanced Generic Corporation on January 01, 2009. The current certification is valid through December 31, 2025.

How is this Advanced Generic Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45737020916. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45737-209-16
11-Digit CMS (5-4-2)
45737-0209-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.